Skip to content

Optimizing Breathing and Blood Flow in Patients Treated With VA ECMO

Ventilation-Perfusion Matching and PEEP Titration in Patients Undergoing Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation (VA ECMO)

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07141524
Acronym
ECMO-VP
Enrollment
10
Registered
2025-08-26
Start date
2026-01-27
Completion date
2027-02-28
Last updated
2026-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VA-ECMO

Keywords

Ventilation / perfusion, ECMO, Mechanical Ventilation

Brief summary

The aim of this study is to characterize ventilation/perfusion (V/Q) matching in adult patients receiving peripheral VA ECMO support while on mechanical ventilation, and to evaluate the impact of PEEP titration guided by Electrical Impedance Tomography (EIT) and esophageal pressure measurements on lung mechanics and V/Q optimization.

Detailed description

The investigators hypothesize that an individualized PEEP titration guided by esophageal pressure measurements and Electrical Impedance Tomography can reduce lung overdistention, enhance lung recruitment, and improve V/Q matching by optimizing regional ventilation and perfusion also in VA ECMO. Our objectives are: 1. To describe V/Q matching in patients undergoing mechanical ventilation during peripheral VA ECMO support. 2. To explore the impact of PEEP titration based on esophageal pressure and EIT in terms of lung mechanics and V/Q matching.

Interventions

OTHERPhysiology measurements

Measurement of lung perfusion (via EIT) and transpulmonary pressure (via esophageal manometry) during decremental PEEP trial

Sponsors

Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (≥18 years) undergoing mechanical ventilation during peripheral VA ECMO support for cardiogenic shock, cardiac arrest, or refractory heart failure. * On ECMO support for at least 6 hours * Swan-Ganz catheter required as standard clinical care * Clinically stable in the estimation of the study investigator

Exclusion criteria

* Contraindications to EIT (e.g., presence of electrical interference) * Patients without pulmonary flow (non-pulsatile pulmonary pressure) * Patients with known pulmonary embolism * Imminent withdrawal of life support

Design outcomes

Primary

MeasureTime frameDescription
V/Q match1 hourPrimary outcome measure: Reduction in shunt fraction (expressed in %) Secondary outcome measure: Reduction in dead space (expressed as volume) Respiratory mechanics will be recorded before and after best PEEP. Ventilation (L/min)/Perfusion (L/min) \[V/Q\] ratio comparing baseline with best PEEP (after PEEP optimization trial).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 27, 2026